Viking Therapeutics, Inc. VKTX 深 沪
等待开盘 07-02 09:30:00 美东时间
37.48
-1.530
-3.92%
华盛通- 最 高39.665
- 今 开38.945
- 成交量 310.80万股
- 最 低 36.96
- 昨 收 39.01
- 总市值 43.52亿
- 52周最高 43.15
- 市盈率 静 --
- 换手率 2.68%
- 52周最低 22.959
- 委 比 -1.07%
- 总股本 1.16亿
- 历史最高 99.41
- 量 比 0.79
- 振 幅 6.93%
- 历史最低 0.88
- 每 手 1
- 风险率 3.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Chip Bloodbath Hits Nasdaq 100 As South Korea Plunges: Stock Market Today
U.S. stocks splintered Tuesday as a violent global sell-off in semiconductor shares hammered the Nasdaq, even as a rotation into defensive sectors and small caps kept the Dow Jones in positive territory through midday trading. • SanDisk stock is showing notable weakness. What’s weighing on SNDK shar...
06-24 00:45
美股大行评级 | 瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
05-29 18:09
Lake Street Initiates Coverage On Viking Therapeutics with Buy Rating, Announces Price Target of $89
Lake Street analyst Daniel Brims initiates coverage on Viking Therapeutics (NASDAQ:VKTX) with a Buy rating and announces Price Target of $89.
05-29 01:20
Viking Therapeutics Presents Additional Data From Phase 2 VENTURE-Oral Dosing Trial Evaluating Oral Tablet Formulation Of VK2735 At ECO In Istanbul, Türkiye
Oral VK2735 demonstrated early, progressive weight loss from Week 1 through Week 13 without a plateauDose-dependent weight loss observed across all VK2735 cohorts, with the highest dose achieving a mean reduction of up
05-12 19:19
Stock Market Today: Oil Jumps 5%, S&P 500 Drops As Iran Strikes UAE Port
U.S. stocks sank Monday as an Iranian drone attack on a UAE petroleum site sent Brent above $114, gold tumbled 2%, and FedEx, UPS and GXO cratered after Amazon expanded its logistics business
05-05 01:34
美股大行评级 | 潜在涨幅128.69%！Immunic获HC Wainwright & Co.升目标价至22美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immunic"买入"评级，目标价从5美元升至22美元；花旗：维持ServiceNow"买入"评级，目标价从154美元升至158美元
05-01 10:49
Cantor Fitzgerald Maintains Overweight on Viking Therapeutics, Lowers Price Target to $100
Cantor Fitzgerald analyst Steve Seedhouse maintains Viking Therapeutics (NASDAQ:VKTX) with a Overweight and lowers the price target from $105 to $100.
04-30 21:59
财报速睇 | Viking Therapeutics, Inc. 2026财年Q1营收0.00亿美元，同比增长0.0%；归母净利润亏损1.58亿美元，同比亏损扩大243.5%
华盛资讯4月30日讯，Viking Therapeutics, Inc.公布2026财年Q1业绩，公司Q1营收0.00亿美元，同比增长0.0%，归母净利润亏损1.58亿美元，同比亏损扩大243.5%。
04-30 18:47
财报速睇 | Viking Therapeutics, Inc. 2026财年Q1营收0.00亿美元，同比增长0.0%；归母净利润亏损1.58亿美元，同比亏损扩大243.5%
华盛资讯4月30日讯，Viking Therapeutics, Inc.公布2026财年Q1业绩，公司Q1营收0.00亿美元，同比增长0.0%，归母净利润亏损1.58亿美元，同比亏损扩大243.5%。
04-30 05:16
Earnings Scheduled For April 29, 2026
Companies Reporting Before The Bell • Extreme Networks (NASDAQ:EXTR) is likely ...
04-29 19:11
